Extended [13C]galactose oxidation studies in patients with galactosemia

Molecular Genetics and Metabolism

Volumn 82, Issue 2, 2004, Pages 130-136

  Berry, Gerard T ^a,b   Reynolds, Robert A ^a   Yager, Claire T ^a   Segal, Stanton ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

1 13C Galactose; Breath test; Galactosemia; Stable isotope

Indexed keywords

GALACTOSE 1 PHOSPHATE URIDYLYLTRANSFERASE; CARBON; GALACTOSE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; GALACTOSEMIA; GENE MUTATION; GENOTYPE; HOMOZYGOSITY; HUMAN; MALE; OXIDATION; PRIORITY JOURNAL; STEADY STATE; URINARY EXCRETION; BREATH ANALYSIS; CLINICAL TRIAL; METABOLISM; OXIDATION REDUCTION REACTION; PRESCHOOL CHILD;

ADOLESCENT; ADULT; BREATH TESTS; CARBON ISOTOPES; CHILD; CHILD, PRESCHOOL; FEMALE; GALACTOSE; GALACTOSEMIAS; HUMANS; MALE; OXIDATION-REDUCTION;

EID: 2542488313     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymgme.2004.03.003     Document Type: Article

References (25)

1. Segal S., Berry G.T. Disorders of galactose metabolism. Scriver C.R., Beaudet A.L., Sly W.S., Valle D. The Metabolic and Molecular Bases of Inherited Diseases. 1995;967-1000 McGraw Hill, New York
2. 14C labeled galactose by subjects with congenital galactosemia. Science. 136:1962;150-151
3. Segal S., Blair A., Roth H. The metabolism of galactose by patients with congenital galactosemia. Am. J. Med. 38:1965;62-70
4. 14galactose by patients with congenital galactosemia. Am. J. Med. 44:1968;340-347
5. Cuatrecasas P., Segal S. Galactose conversion to D-xylulose: an alternate route of galactose metabolism. Science. 153:1966;549-551
6. 13C]galactose in patients with galactose-1-phosphate uridyltransferase deficiency. Biochem. Mol. Med. 56:1995;158-165
7. Berry G.T., Nissim I., Gibson J.B., Lin Z., Elsas L.J., Singh R.H., Klein P.D., Segal S. Quantitative assessment of whole body galactose metabolism in galactosemic patients. Eur. J. Pediatr. 156:1997;S43-S49
8. Berry G.T., Sing R.H., Mazur A.T., Guerrero N., Kennedy M.J., Chen J., Reynolds R.A., Palmieri M.J., Klein P.B., Segal S., Elsas L.J. Galactose breath testing distinguishes variant and severe galactose-1-phosphate uridyltransferase genotypes. Pediatr. Res. 48:2000;23-328
9. Lai K., Langley S.D., Singh R.H., Dembure P.P., Hjelm L.N., Elsas L.J. A prevalent mutation for galactosemia among black Americans. J. Pediatr. 128:1996;89-95
10. Berry G.T., Nissim I., Lin Z., Mazur A.T., Gibson J.B., Segal S. Endogenous synthesis of galactose in normal man and patients with hereditary galactosemia. The Lancet. 346:1995;1073-1074
11. Berry G.T., Moate P.J., Reynolds R.A., Yager C.T., Ning C., Boston R.C., Segal S. The rate of de novo galactose synthesis in patients with galactose-1-phosphate uridyltransferase deficiency. Mol. Genet. Metab. 81:2004;22-30
12. Schadewaldt P., Kamalanathan L., Hammen H.-W., Wendel U. Age dependence of endogenous galactose formation in Q188R homozygous galactosemic patients. Mol. Genet. Metab. 81:2004;31-44
13. Ning C., Segal S. Plasma galactose and galactitol concentration in patients with galactose-1-phosphate uridyltransferase deficiency galactosemia: determination by gas chromatography/mass spectrometry. Metabolism. 49:2000;1460-1466
14. Chen J., Yager C., Reynolds R., Palmieri M., Segal S. Erythrocyte galactose 1-phosphate quantified by isotope-dilution gas chromatography-mass spectrometry. Clin. Chem. 48:2002;283-289
15. Yager C.T., Chen J., Reynolds R., Segal S. Galactitol and galactonate in red blood cells of galactosemic patients. Mol. Genet. Metab. 80:2003;283-289
16. Palmieri M., Mazur A., Berry G.T., Ning C., Wehrli S., Yager C., Reynolds R., Singh R., Muralidharan K., Langley S., Elsas L. II, Segal S. Urine and plasma galactitol in patients with galactose-1-phosphate uridyltransferase deficiency galactosemia. Metabolism. 48:1999;1294-1302
17. Wehrli S.L., Berry G.T., Palmieri M., Mazur A., Elsas L. III, Segal S. Urinary galactonate in patients with galactosemia: quantitation by nuclear magnetic resonance spectroscopy. Pediatr. Res. 42:1997;855-861
18. Berry G.T., Leslie N., Reynolds R.A., Yager C.T., Segal S. Evidence for alternate galactose oxidation in a patient with deletion of the galactose-1-phosphate uridyltransferase gene. Mol. Genet. Metab. 72:2001;316-321
19. Schoeller D.A., Klein P.D. A microprocessor controlled mass spectrometer for the fully automated purification and isotopic analysis of breath carbon dioxide. Biomed. Mass Spectrom. 6:1979;350-355
20. Schofield W.N. Predicting basal metabolic rate, new standards and review of previous work. Hum. Nutr. Clin. Nutr. C. 39(Suppl. 1):1985;5-41
21. de Weir J.R. New methods for calculating metabolic rate with special reference to protein metabolism. J. Physiol. 109:1949;1-9
22. Holton J.B., Walter J.H., Tyfield L.A. Galactosemia. Scriver C.R., Beaudet A.L., Sly W.S., Valle D. The Metabolic and Molecular Bases of Inherited Diseases. eighth ed. 2001;1553-1587 McGraw Hill, New York
23. 13C galactose by lymphoblasts from patients with galactosemia determined by NMR spectroscopy. Mol. Genet. Metab. 77:2002;296-303
24. Abraham H.D., Howell R.R. Human hepatic uridine diphosphate galactose pyrophosphorylase. J. Biol. Chem. 244:1969;545-550
25. Gitzelmann R. Formation of galactose-1-phosphate form uridine diphosphate in erythrocytes from patients with galactosemia. Pediatr. Res. 3:1969;279-286